Holers VM - Search Results

1

Kemper C, Ferreira VP, Paz JT, Holers VM, Lionakis MS, Alexander JJ. Kemper C, et al. Among authors: holers vm. J Immunol. 2023 Jan 15;210(2):119-125. doi: 10.4049/jimmunol.2200540. J Immunol. 2023. PMID: 36596217 Free PMC article. Review.

2

Genetics of the complement system and rheumatic diseases.

Moulds JM, Krych M, Holers VM, Liszewski MK, Atkinson JP. Moulds JM, et al. Among authors: holers vm. Rheum Dis Clin North Am. 1992 Nov;18(4):893-914. Rheum Dis Clin North Am. 1992. PMID: 1455049 Review.

3

Characterization of C3 receptors on cultured rat glomerular endothelial cells.

Alexander JJ, He C, Adler S, Holers VM, Quigg RJ. Alexander JJ, et al. Among authors: holers vm. Kidney Int. 1997 Apr;51(4):1124-32. doi: 10.1038/ki.1997.155. Kidney Int. 1997. PMID: 9083278 Free article.

4

Characterization of C3-binding proteins on mouse neutrophils and platelets.

Quigg RJ, Alexander JJ, Lo CF, Lim A, He C, Holers VM. Quigg RJ, et al. Among authors: holers vm. J Immunol. 1997 Sep 1;159(5):2438-44. J Immunol. 1997. PMID: 9278336

5

An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.

Makar KW, Pham CT, Dehoff MH, O'Connor SM, Jacobi SM, Holers VM. Makar KW, et al. Among authors: holers vm. J Immunol. 1998 Feb 1;160(3):1268-78. J Immunol. 1998. PMID: 9570543

6

Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM. Quigg RJ, et al. Among authors: holers vm. J Exp Med. 1998 Oct 5;188(7):1321-31. doi: 10.1084/jem.188.7.1321. J Exp Med. 1998. PMID: 9763611 Free PMC article.

7

Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.

Boackle SA, Morris MA, Holers VM, Karp DR. Boackle SA, et al. Among authors: holers vm. J Immunol. 1998 Dec 15;161(12):6537-43. J Immunol. 1998. PMID: 9862679

8

Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.

Alexander JJ, Lim A, He C, MacDonald RL, Holers VM, Quigg RJ. Alexander JJ, et al. Among authors: holers vm. Immunopharmacology. 1999 May;42(1-3):245-54. doi: 10.1016/s0162-3109(99)00010-7. Immunopharmacology. 1999. PMID: 10408385

9

Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.

Marchbank KJ, Watson CC, Ritsema DF, Holers VM. Marchbank KJ, et al. Among authors: holers vm. J Immunol. 2000 Sep 1;165(5):2354-61. doi: 10.4049/jimmunol.165.5.2354. J Immunol. 2000. PMID: 10946257

10

Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.

Cunningham PN, Holers VM, Alexander JJ, Guthridge JM, Carroll MC, Quigg RJ. Cunningham PN, et al. Among authors: holers vm. Kidney Int. 2000 Oct;58(4):1580-7. doi: 10.1046/j.1523-1755.2000.00319.x. Kidney Int. 2000. PMID: 11012892 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters